Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Cancer Center of Kansas
27
mi
from
Wichita, KA
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Cancer Center of Kansas
27
mi
from
Wichita, KA
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
University of Maryland
1148
mi
from
Baltimore, MD
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
University of Maryland
1148
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
1149
mi
from
Baltimore, MD
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
1149
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Kansas City Veterans Affairs Medical Center
198
mi
from
Kansas City, MO
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Kansas City Veterans Affairs Medical Center
198
mi
from
Kansas City, MO
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Nevada Cancer Institute
971
mi
from
Las Vegas, NV
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Nevada Cancer Institute
971
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Montefiore Medical Center
1293
mi
from
Bronx, NY
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Montefiore Medical Center
1293
mi
from
Bronx, NY
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
North Shore Hematology Oncology Associates
1334
mi
from
East Setauket, NY
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
North Shore Hematology Oncology Associates
1334
mi
from
East Setauket, NY
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Goshen Medical Associates
1271
mi
from
Goshen, NY
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Goshen Medical Associates
1271
mi
from
Goshen, NY
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Stony Brook University Medical Center
1358
mi
from
Stony Brook, NY
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Stony Brook University Medical Center
1358
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Kaiser Permanente Oncology/Hematology
1384
mi
from
Portland, OR
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Kaiser Permanente Oncology/Hematology
1384
mi
from
Portland, OR
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Oregon Health and Science University
1383
mi
from
Portland, OR
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Oregon Health and Science University
1383
mi
from
Portland, OR
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Carolina Urologic Research Center
1099
mi
from
Myrtle Beach, SC
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Carolina Urologic Research Center
1099
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Scott and White Memorial Hospital & Clinic
464
mi
from
Temple, TX
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Scott and White Memorial Hospital & Clinic
464
mi
from
Temple, TX
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Utah Cancer Specialists
777
mi
from
Salt Lake City, UT
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Utah Cancer Specialists
777
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Providence Regional Medical Center Everett
1413
mi
from
Everett, WA
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Providence Regional Medical Center Everett
1413
mi
from
Everett, WA
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Southern California Permanente Medical Group
1136
mi
from
San Diego, CA
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Southern California Permanente Medical Group
1136
mi
from
San Diego, CA
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Hematology Oncology Associates of Treasure Coast
1247
mi
from
Port Saint Lucie, FL
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Hematology Oncology Associates of Treasure Coast
1247
mi
from
Port Saint Lucie, FL
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Northside Hospital
798
mi
from
Atlanta, GA
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Northside Hospital
798
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Augusta University
936
mi
from
Augusta, GA
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Augusta University
936
mi
from
Augusta, GA
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Gwinnett Hospital System Inc.
816
mi
from
Lawrenceville, GA
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Gwinnett Hospital System Inc.
816
mi
from
Lawrenceville, GA
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Goshen Center for Cancer Care
688
mi
from
Goshen, IN
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Goshen Center for Cancer Care
688
mi
from
Goshen, IN
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
The Mayo Clinic
515
mi
from
Rochester, MN
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
The Mayo Clinic
515
mi
from
Rochester, MN
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Comprehensive Cancer Centers of Nevada
970
mi
from
Las Vegas, NV
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Comprehensive Cancer Centers of Nevada
970
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
SUNY Upstate Medical University
1193
mi
from
Syracuse, NY
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
SUNY Upstate Medical University
1193
mi
from
Syracuse, NY
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Novant Health Oncology Specialists
971
mi
from
Winston Salem, NC
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Novant Health Oncology Specialists
971
mi
from
Winston Salem, NC
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Tulsa Cancer Institute, Pllc
149
mi
from
Tulsa, OK
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Tulsa Cancer Institute, Pllc
149
mi
from
Tulsa, OK
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
St. Luke'S Hospital & Health Network Laboratory
1040
mi
from
Bethlehem, PA
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
St. Luke'S Hospital & Health Network Laboratory
1040
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Cancer Center of the Carolinas
882
mi
from
Greenville, SC
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Cancer Center of the Carolinas
882
mi
from
Greenville, SC
Click here to add this to my saved trials
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated:  9/2/2015
Local Institution
5438
mi
from
Rosario,
Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer
Randomized, Double-Blind, Phase 3 Trial to Compare the Efficacy of Ipilimumab vs Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naïve Castration Resistant Prostate Cancer
Status: Enrolling
Updated: 9/2/2015
Local Institution
5438
mi
from
Rosario,
Click here to add this to my saved trials
Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma
Stereotactic Boost for Poor-Prognosis Oropharyngeal Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/2/2015
Dana-Farber Cancer Institute
1444
mi
from
Boston, MA
Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma
Stereotactic Boost for Poor-Prognosis Oropharyngeal Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/2/2015
Dana-Farber Cancer Institute
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma
Stereotactic Boost for Poor-Prognosis Oropharyngeal Squamous Cell Carcinoma
Status: Enrolling
Updated:  9/2/2015
Brigham and Women's Hosp
1444
mi
from
Boston, MA
Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma
Stereotactic Boost for Poor-Prognosis Oropharyngeal Squamous Cell Carcinoma
Status: Enrolling
Updated: 9/2/2015
Brigham and Women's Hosp
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer
Phase II Trial of Neoadjuvant Dose Dense Gemcitabine and Cisplatin In Muscle Invasive Bladder Cancer
Status: Enrolling
Updated:  9/2/2015
Thomas Jefferson University [Kimmel Cancer Center]
1225
mi
from
Philadelphia, PA
Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer
Phase II Trial of Neoadjuvant Dose Dense Gemcitabine and Cisplatin In Muscle Invasive Bladder Cancer
Status: Enrolling
Updated: 9/2/2015
Thomas Jefferson University [Kimmel Cancer Center]
1225
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer
Phase II Trial of Neoadjuvant Dose Dense Gemcitabine and Cisplatin In Muscle Invasive Bladder Cancer
Status: Enrolling
Updated:  9/2/2015
Fox Chase Cancer Center
1229
mi
from
Philadelphia, PA
Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer
Phase II Trial of Neoadjuvant Dose Dense Gemcitabine and Cisplatin In Muscle Invasive Bladder Cancer
Status: Enrolling
Updated: 9/2/2015
Fox Chase Cancer Center
1229
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pancreatic Juice Diagnosis From Duodenum
Pancreatic Juice Diagnosis From Duodenum
Status: Enrolling
Updated:  9/2/2015
Mayo Clinic, Jacksonville
1061
mi
from
Jacksonville, FL
Pancreatic Juice Diagnosis From Duodenum
Pancreatic Juice Diagnosis From Duodenum
Status: Enrolling
Updated: 9/2/2015
Mayo Clinic, Jacksonville
1061
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Pancreatic Juice Diagnosis From Duodenum
Pancreatic Juice Diagnosis From Duodenum
Status: Enrolling
Updated:  9/2/2015
Kyushu University
mi
from
Fukuoka-shi,
Pancreatic Juice Diagnosis From Duodenum
Pancreatic Juice Diagnosis From Duodenum
Status: Enrolling
Updated: 9/2/2015
Kyushu University
mi
from
Fukuoka-shi,
Click here to add this to my saved trials
Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery
Phase II Trial of Single Fraction Radiation Therapy (SFRT) at Roswell Park Cancer Institute for Select Patients With Early Stage Breast Cancer
Status: Enrolling
Updated:  9/2/2015
Roswell Park Cancer Institute
1057
mi
from
Buffalo, NY
Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery
Phase II Trial of Single Fraction Radiation Therapy (SFRT) at Roswell Park Cancer Institute for Select Patients With Early Stage Breast Cancer
Status: Enrolling
Updated: 9/2/2015
Roswell Park Cancer Institute
1057
mi
from
Buffalo, NY
Click here to add this to my saved trials
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated:  9/2/2015
Arizona Cancer Center at University of Arizona Health Sciences Center
427
mi
from
Tuscon, AZ
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated: 9/2/2015
Arizona Cancer Center at University of Arizona Health Sciences Center
427
mi
from
Tuscon, AZ
Click here to add this to my saved trials
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated:  9/2/2015
Kaiser Permanente Medical Center - Oakland
1327
mi
from
Oakland, CA
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated: 9/2/2015
Kaiser Permanente Medical Center - Oakland
1327
mi
from
Oakland, CA
Click here to add this to my saved trials
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated:  9/2/2015
University of Colorado Cancer Center at University of Colorado Health Sciences Center
403
mi
from
Aurora, CO
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated: 9/2/2015
University of Colorado Cancer Center at University of Colorado Health Sciences Center
403
mi
from
Aurora, CO
Click here to add this to my saved trials
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated:  9/2/2015
Rush-Copley Cancer Care Center
576
mi
from
Aurora, IL
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated: 9/2/2015
Rush-Copley Cancer Care Center
576
mi
from
Aurora, IL
Click here to add this to my saved trials
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated:  9/2/2015
St. Joseph Medical Center
508
mi
from
Bloomington, IL
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated: 9/2/2015
St. Joseph Medical Center
508
mi
from
Bloomington, IL
Click here to add this to my saved trials
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated:  9/2/2015
Graham Hospital
460
mi
from
Canton, IL
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated: 9/2/2015
Graham Hospital
460
mi
from
Canton, IL
Click here to add this to my saved trials
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated:  9/2/2015
Memorial Hospital
403
mi
from
Carthage, IL
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated: 9/2/2015
Memorial Hospital
403
mi
from
Carthage, IL
Click here to add this to my saved trials
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated:  9/2/2015
Eureka Hospital
501
mi
from
Eureka, IL
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated: 9/2/2015
Eureka Hospital
501
mi
from
Eureka, IL
Click here to add this to my saved trials
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated:  9/2/2015
Galesburg Clinic, PC
455
mi
from
Galesburg, IL
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated: 9/2/2015
Galesburg Clinic, PC
455
mi
from
Galesburg, IL
Click here to add this to my saved trials
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated:  9/2/2015
Galesburg Cottage Hospital
455
mi
from
Galesburg, IL
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated: 9/2/2015
Galesburg Cottage Hospital
455
mi
from
Galesburg, IL
Click here to add this to my saved trials
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated:  9/2/2015
InterCommunity Cancer Center of Western Illinois
455
mi
from
Galesburg, IL
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated: 9/2/2015
InterCommunity Cancer Center of Western Illinois
455
mi
from
Galesburg, IL
Click here to add this to my saved trials
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated:  9/2/2015
Mason District Hospital
452
mi
from
Havana, IL
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated: 9/2/2015
Mason District Hospital
452
mi
from
Havana, IL
Click here to add this to my saved trials
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated:  9/2/2015
Hopedale Medical Complex
486
mi
from
Hopedale, IL
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated: 9/2/2015
Hopedale Medical Complex
486
mi
from
Hopedale, IL
Click here to add this to my saved trials
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated:  9/2/2015
Joliet Oncology-Hematology Associates, Limited - West
578
mi
from
Joliet, IL
Screening Tests in Detecting Colorectal Cancer
Colorectal Cancer Screening: Fecal Blood vs. DNA
Status: Enrolling
Updated: 9/2/2015
Joliet Oncology-Hematology Associates, Limited - West
578
mi
from
Joliet, IL
Click here to add this to my saved trials